Research

Hold Pfizer India Ltd - Kotak Securities PCG

Posted On : 2006-10-03 04:49:41( TIMEZONE : IST )

Kotak Securities has given a Hold rating on Pfizer India Ltd. The current market price of Pfizer India Ltd is Rs.900.

Source : Kotak Securities

Keywords

Interesting Articles

43% of MSME Loans in Tamil Nadu Directed to Manufacturing; Private Banks Lead with 39% Share
GDP growth to print at 6.9% in Q4 FY2025, limiting FY2025 expansion to 6.3%: ICRA
OEM-Wise Divergence Dominates April Performance; Tractors and 2Ws Poised for Growth - Asit C. Mehta Investment Interrmediates Ltd Monthly Auto Sales Report - April 2025
Markets rebound despite tariff overhang - Vinay Paharia, CIO, PGIM India Mutual Fund
CRISIL Ratings: Agrochemicals sector to see 7-9% growth amid modest exports
SBI Capital Markets: RBI Monetary Policy Dec'24 - RBI faces arduous task of managing all dynamics: Liquidity, Currency, Growth and Inflation
SBICAPS Monthly Ecocapsule Dec'24 : FY25 - A TALE OF TWO HALVES OR ONE OF FULL DESPAIR? - Executive Summary
CRISIL Ratings: Revenue growth of organised luggage makers to halve to 8-10%
CRISIL Ratings - Cement demand to grow at a moderate pace of 7-8% this fiscal
CRISIL Ratings: For small finance banks, RoA to dip ~40 bps this fiscal
Securitisation volumes witness strong growth; likely to reach ~Rs. 60,000 crore in Q2 FY2025: ICRA
CRISIL Ratings: Operating losses of state discoms to stay high despite 15-20% dip
CRISIL Ratings: Tamil Nadu garment exporters to see 8-10% revenue growth
CRISIL MI&A: Inflated natural rubber prices to puncture tyre maker margins
Infrastructure bond issuances by public sector banks to drive banks' bond issuances to an all-time high in FY2025: ICRA
CRISIL Ratings: Apparel retailers to stitch 8-10% growth with festivals, fast fashion
CRISIL Ratings: For ARCs, rising power consumption to boost recoveries from stressed operational thermal plants
Views of ICAI on SA 600 vs ISA 600
CRISIL Ratings: Wagon makers set to roll in ~20% revenue growth this fiscal
CRISIL Ratings: Basmati industry to see revenue grow ~4% on a high base this fiscal
CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
CRISIL Ratings: Flexible packaging players' credit profiles to stay subdued this fiscal
Industry credit expected to grow over 12 per cent: FICCI-IBA Bankers' Survey
CRISIL Ratings: Decadal-low duty to push gold jewellery retailers' revenues up by 22-25%